Condensed Consolidated Statements Of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	At-The-Market Offering	Common Stock	Common Stock At-The-Market Offering	Additional Paid-in Capital	Additional Paid-in Capital At-The-Market Offering	Accumulated Deficit
Beginning Balance at Dec. 31, 2021	$ 632,497		$ 2		$ 663,614		$ (31,119)
Beginning Balance, Shares at Dec. 31, 2021			20,825,000
Stock-based compensation expense	15,237				15,237
Net income (loss)	6,140						6,140
Issuance of shares upon vesting of restricted stock units, net of tax withholdings, Shares			217,000
Ending Balance at Mar. 31, 2022	653,874		$ 2		678,851		(24,979)
Ending Balance, Shares at Mar. 31, 2022			21,042,000
Beginning Balance at Dec. 31, 2022	$ 708,480		$ 2		716,343		(7,865)
Beginning Balance, Shares at Dec. 31, 2022	21,702,000		21,702,000
Stock-based compensation expense	$ 19,136				19,136
Net income (loss)	(16,490)						(16,490)
Issuance of common stock net of underwriting discounts and commissions and other offering costs		$ 12,749				$ 12,749
Issuance of common stock net of underwriting discounts and commissions and other offerings costs, Shares				100,000
Issuance of shares upon vesting of restricted stock units, net of tax withholdings	(10,215)				(10,215)
Issuance of shares upon vesting of restricted stock units, net of tax withholdings, Shares			150,000
Ending Balance at Mar. 31, 2023	$ 713,660		$ 2		$ 738,013		$ (24,355)
Ending Balance, Shares at Mar. 31, 2023	21,952,000		21,952,000